Patent · US Active

Differentiating ES cells using a tenascin

US9334478B2 · kind B2 · utility

1Cited by
24References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 2009
Grant dateMay 10, 2016
Priority date
Expiry dateSep 10, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention relates to assays for screening growth factors, adhesion molecules, immunostimulatory molecules, extracellular matrix components and other materials, alone or in combination, simultaneously or temporally, for the ability to induce directed differentiation of pluripotent and multipotent stem cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.